Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement
Background: In Germany, oral HIV pre-exposure prophylaxis (PrEP) was licensed in 2016. Health insurances have been covering the costs since 09/2019. This study compares the sociodemographic profiles of PrEP users before and after PrEP re-imbursement. Methods: Participants were recruited in a cross-s...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Journal of Infection and Public Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034122001915 |
_version_ | 1811281007857369088 |
---|---|
author | Patrick Ahaus Axel J. Schmidt Adriane Skaletz-Rorowski Mona Uhrmacher Katja Serova Arne Kayser Janet Wach Sandeep Nambiar Norbert H. Brockmeyer Anja Potthoff |
author_facet | Patrick Ahaus Axel J. Schmidt Adriane Skaletz-Rorowski Mona Uhrmacher Katja Serova Arne Kayser Janet Wach Sandeep Nambiar Norbert H. Brockmeyer Anja Potthoff |
author_sort | Patrick Ahaus |
collection | DOAJ |
description | Background: In Germany, oral HIV pre-exposure prophylaxis (PrEP) was licensed in 2016. Health insurances have been covering the costs since 09/2019. This study compares the sociodemographic profiles of PrEP users before and after PrEP re-imbursement. Methods: Participants were recruited in a cross-sectoral sexual health centre in Germany. baseline data were compared for 139 vs 138 individuals starting PrEP from 10/2017–12/2018 (pre-reimbursement cohort) and 09/2019–3/2020; respectively. The pre-reimbursement cohort was further analysed with respect to sexual behaviour and incident sexually transmitted infections (STIs). Results: There were no significant differences in the sociodemographic characteristics between the two cohorts. Almost all PrEP users were men-who-have-sex-with-men (MSM). Before reimbursement, fewer individuals used PrEP on a daily base, and more had used PrEP prior to enrolment. During follow-up (pre-reimbursement cohort), the number of sexual and condomless intercourse partners increased, so did the proportion engaging in Chemsex. Incidences of infections with C.trachomatis, N.gonorrhoeae, M.genitalium, and T.pallidum were 45.2; 36.8; 30.1; and 9.2, respectively, per 100 person-years. Conclusion: The goal to make PrEP available to a broader range of people with the covering of costs was only partially reached. Medically supervised use is important to detect and treat STIs. |
first_indexed | 2024-04-13T01:26:03Z |
format | Article |
id | doaj.art-fd5392181846417689d754d69bcc41be |
institution | Directory Open Access Journal |
issn | 1876-0341 |
language | English |
last_indexed | 2024-04-13T01:26:03Z |
publishDate | 2022-09-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Infection and Public Health |
spelling | doaj.art-fd5392181846417689d754d69bcc41be2022-12-22T03:08:38ZengElsevierJournal of Infection and Public Health1876-03412022-09-01159955960Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursementPatrick Ahaus0Axel J. Schmidt1Adriane Skaletz-Rorowski2Mona Uhrmacher3Katja Serova4Arne Kayser5Janet Wach6Sandeep Nambiar7Norbert H. Brockmeyer8Anja Potthoff9Interdisciplinary Immunological Outpatient Clinic, Department of Dermatology, Venereology and Allergology, Ruhr University Bochum, Germany; WIR – Walk In Ruhr – Center for Sexual Health and Medicine, Bochum, GermanySigma Research, Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, United Kingdom; Division of Infectious Diseases, Cantonal Hospital St. Gallen, SwitzerlandInterdisciplinary Immunological Outpatient Clinic, Department of Dermatology, Venereology and Allergology, Ruhr University Bochum, Germany; WIR – Walk In Ruhr – Center for Sexual Health and Medicine, Bochum, GermanyInterdisciplinary Immunological Outpatient Clinic, Department of Dermatology, Venereology and Allergology, Ruhr University Bochum, Germany; WIR – Walk In Ruhr – Center for Sexual Health and Medicine, Bochum, GermanyInstitute of Educational Research, Ruhr Universität Bochum, Bochum, GermanyWIR – Walk In Ruhr – Center for Sexual Health and Medicine, Bochum, Germany; Aids Service Organization Bochum e. V., GermanyWIR – Walk In Ruhr – Center for Sexual Health and Medicine, Bochum, Germany; Local Health Authority Bochum, GermanyInterdisciplinary Immunological Outpatient Clinic, Department of Dermatology, Venereology and Allergology, Ruhr University Bochum, Germany; WIR – Walk In Ruhr – Center for Sexual Health and Medicine, Bochum, GermanyInterdisciplinary Immunological Outpatient Clinic, Department of Dermatology, Venereology and Allergology, Ruhr University Bochum, Germany; WIR – Walk In Ruhr – Center for Sexual Health and Medicine, Bochum, GermanyInterdisciplinary Immunological Outpatient Clinic, Department of Dermatology, Venereology and Allergology, Ruhr University Bochum, Germany; WIR – Walk In Ruhr – Center for Sexual Health and Medicine, Bochum, Germany; Corresponding author at: WIR – Walk In Ruhr, Center for Sexual Health and Medicine, Grosse Beckstrasse 12, 44787 Bochum, Germany.Background: In Germany, oral HIV pre-exposure prophylaxis (PrEP) was licensed in 2016. Health insurances have been covering the costs since 09/2019. This study compares the sociodemographic profiles of PrEP users before and after PrEP re-imbursement. Methods: Participants were recruited in a cross-sectoral sexual health centre in Germany. baseline data were compared for 139 vs 138 individuals starting PrEP from 10/2017–12/2018 (pre-reimbursement cohort) and 09/2019–3/2020; respectively. The pre-reimbursement cohort was further analysed with respect to sexual behaviour and incident sexually transmitted infections (STIs). Results: There were no significant differences in the sociodemographic characteristics between the two cohorts. Almost all PrEP users were men-who-have-sex-with-men (MSM). Before reimbursement, fewer individuals used PrEP on a daily base, and more had used PrEP prior to enrolment. During follow-up (pre-reimbursement cohort), the number of sexual and condomless intercourse partners increased, so did the proportion engaging in Chemsex. Incidences of infections with C.trachomatis, N.gonorrhoeae, M.genitalium, and T.pallidum were 45.2; 36.8; 30.1; and 9.2, respectively, per 100 person-years. Conclusion: The goal to make PrEP available to a broader range of people with the covering of costs was only partially reached. Medically supervised use is important to detect and treat STIs.http://www.sciencedirect.com/science/article/pii/S1876034122001915HIV-Pre-Exposure ProphylaxisSexual behaviourSexually transmitted infections (STIs)Men who have sex with men (MSM)Condom use |
spellingShingle | Patrick Ahaus Axel J. Schmidt Adriane Skaletz-Rorowski Mona Uhrmacher Katja Serova Arne Kayser Janet Wach Sandeep Nambiar Norbert H. Brockmeyer Anja Potthoff Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement Journal of Infection and Public Health HIV-Pre-Exposure Prophylaxis Sexual behaviour Sexually transmitted infections (STIs) Men who have sex with men (MSM) Condom use |
title | Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement |
title_full | Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement |
title_fullStr | Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement |
title_full_unstemmed | Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement |
title_short | Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement |
title_sort | changes in the user profiles of hiv pre exposure prophylaxis prep before and after prep reimbursement |
topic | HIV-Pre-Exposure Prophylaxis Sexual behaviour Sexually transmitted infections (STIs) Men who have sex with men (MSM) Condom use |
url | http://www.sciencedirect.com/science/article/pii/S1876034122001915 |
work_keys_str_mv | AT patrickahaus changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT axeljschmidt changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT adrianeskaletzrorowski changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT monauhrmacher changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT katjaserova changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT arnekayser changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT janetwach changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT sandeepnambiar changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT norberthbrockmeyer changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement AT anjapotthoff changesintheuserprofilesofhivpreexposureprophylaxisprepbeforeandafterprepreimbursement |